# What Laboratory Tests Found in Melanotan II Products

- Article ID: research-410
- Product: Melanotan II (melanotan-ii-444)
- Canonical page: https://heritagebiolabs.com/research-library/articles/410-what-laboratory-tests-found-in-melanotan-ii-products
- Product collection: https://heritagebiolabs.com/research-library/products/melanotan-ii
- Product page: https://heritagebiolabs.com/product/melanotan-ii-444
- Reading focus: Methods & identity (Reading focus is a navigational tag, not an evidence grade.)
- Source years: 2024, 2026

> Educational article about published research. For research use only; not medical advice. Literature does not establish the identity, purity or activity of a purchased lot, and studies of individual components do not validate a blend.

Peptides are short chains of amino acids joined by peptide bonds. A product name tells a reader which peptide a label claims to contain. Testing is how a laboratory checks what is actually there. In August 2026, Australia's Therapeutic Goods Administration reported that several bottles labeled with the same amount of Melanotan II contained substantially different amounts. [1]

The agency confirmed that the five seized bottles it tested contained Melanotan II. Using the liquid volume stated on each label, the lab estimated total peptide amounts ranging from about three quarters to 1.8 times the amount the packaging claimed. Those figures describe the estimated contents of the entire bottles. They do not measure how much any person was exposed to, or what happened after exposure. The sample came from one investigation, so the results also cannot establish how often products from other sources differ from their labels. [1]

A separate forensic report published in 2024 described the challenge of identifying powder in two vials labeled Melanotan II. An initial comparison against a library of chemical signatures did not return a match. The team compared the powder with a reference standard and used mass spectrometry, which helps distinguish molecules by mass and electrical charge, to confirm the peptide's identity. The authors reported a purity of 30 percent in the material they analyzed. That is a result for those samples, not a finding about the bottles tested by the Australian regulator. [2]

The two investigations illustrate the difference between identity, amount and purity. Identity tells the analyst which molecule is present. Amount tells how much of that molecule is in the sample. Purity describes how much of the tested material is the intended compound, under the method used. A test that confirms one property does not answer all the others. These published measurements are useful when reading a case report based only on a person's recollection or a product label: that information can help explain the timeline, but it cannot substitute for a measurement of the product itself. [1, 2]

## Sources

1. Therapeutic Goods Administration. Melanotan II tanning peptide products found to be inconsistently dosed. Australian Government laboratory findings and safety advisory (2026-08-17). <https://www.tga.gov.au/safety/safety-monitoring-and-information/safety-alerts/melanotan-ii-tanning-peptide-products-found-be-inconsistently-dosed>
2. Deville M, Charlier C. Barbie drug identification: Not a child's play. Journal of Forensic Sciences (online 2024-09-20). <https://pubmed.ncbi.nlm.nih.gov/39302005/>

## Provenance

Article titles, body paragraphs and numbered citations extracted without rewriting from owner-supplied Word volumes. Product mappings use exact catalog labels; reading-focus tags and excerpts are navigational metadata. No independent peer-review or comprehensive source verification is claimed. Source volume: Peptide Research Articles 082 - Melanotan II.docx; article 410; content SHA-256 ecb2b73b716ac80cca59cdc1212e8471e07e427b607aa6b4bb427c5eb85dab68.
